Literature DB >> 12740592

Dopamine and Parkinson's disease: is the killer in the house?

M-F Chesselet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12740592     DOI： 10.1038/sj.mp.4001289

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  5 in total

1.  Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.

Authors:  Franziska Richter; Lauryn Gabby; Kimberly A McDowell; Caitlyn K Mulligan; Krystal De La Rosa; Pedrom C Sioshansi; Farzad Mortazavi; Ingrid Cely; Larry C Ackerson; Linda Tsan; Niall P Murphy; Nigel T Maidment; Marie-Françoise Chesselet
Journal:  Neurobiol Aging       Date:  2016-12-01       Impact factor: 4.673

2.  Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons.

Authors:  Shohreh Majd; Arthur Smardencas; Clare L Parish; John Drago
Journal:  Neurochem Res       Date:  2011-03-06       Impact factor: 3.996

Review 3.  A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.

Authors:  Marie-Francoise Chesselet; Franziska Richter; Chunni Zhu; Iddo Magen; Melanie B Watson; Sudhakar R Subramaniam
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 4.  The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases.

Authors:  Felix Prinz; Anita Kapeller; Martin Pichler; Christiane Klec
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

Review 5.  Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms.

Authors:  Norelle C Wildburger; Anna-Sophia Hartke; Alina Schidlitzki; Franziska Richter
Journal:  Front Cell Dev Biol       Date:  2020-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.